ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Presenter(s): Sarah A Cust, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This presentation addresses the underlying neuropathology of ataxia, dysarthria-specific assessment and treatment for degenerative ataxias, and the importance of cognitive assessment and treatment. The presenter highlights recent advances in intervention, including noninvasive brain stimulation.
Presenter(s): Tanya Ramadan; Bronwyn A Hemsley; Rebecca Sullivan
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This course presents a study to determine the views of hospital staff, including speech-language pathologists, on the impact of COVID-19 visitor restrictions on patients or staff. This course discusses the findings of the descriptive and content analysis with implications for stroke rehabilitation.
Presenter(s): Rene L Utianski, PhD, CCC-SLP, BC-ANCDS; Kristie A Spencer, PhD, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Motor speech disorders occur secondary to a wide variety of progressive neurological disorders. This course discusses strategies for the speaker, listener, and environment that clinicians can consider for managing progressive motor speech disorders. Presenters discuss management strategies in the context of concomitant decline of cognitive-linguistic and motoric function from neurodegenerative processes.
Presenter(s): Sharon Sandridge, PhD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This session explores assessment and management options for working with patients who self-report bothersome tinnitus, including counseling, patient/family-centered care, and giving hope to struggling patients.
Presenter(s): Shibani S. Mukerji, MD, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session addresses the question of why patients with COVID-19 have such diverse clinical presentations. The speaker zooms in at the microscopic level to explore the nature and frequency of neurologic sequelae of COVID-19, covering findings observed on neuroimaging and cerebrospinal fluid testing. The session summarizes data from neuropathological studies, discusses new studies on the involvement of the peripheral nervous system, and explores treatment considerations.
Presenter(s): Rebecca J Boersma, MA, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session reviews the emerging evidence of neurological manifestations of COVID-19 and identifies how SLPs can use their unique position to maximize patient outcomes-whether as a member of an interdisciplinary team or as a solo provider. The session strives to increase clinicians' confidence in their abilities to: identify common cognitive-communication symptoms for patients who have recovered from COVID-19, and evaluate and treat with an individualized, patient-centered approach.